Leonard Mazur
2020
In 2020, Leonard Mazur earned a total compensation of $550K as Executive Chairman at Citius Pharmaceuticals, a 16% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $160,000 |
|---|---|
| Option Awards | $140,035 |
| Salary | $250,000 |
| Total | $550,035 |
Mazur received $250K in salary, accounting for 45% of the total pay in 2020.
Mazur also received $160K in non-equity incentive plan and $140K in option awards.
Rankings
In 2020, Leonard Mazur's compensation ranked 10,754th out of 13,090 executives tracked by ExecPay. In other words, Mazur earned more than 17.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,754 out of 13,090 | 18th |
Division Manufacturing | 4,598 out of 5,624 | 18th |
Major group Chemicals And Allied Products | 1,910 out of 2,257 | 15th |
Industry group Drugs | 1,675 out of 1,957 | 14th |
Industry Pharmaceutical Preparations | 1,236 out of 1,462 | 16th |
Source: SEC filing on December 21, 2020.
Mazur's colleagues
We found three more compensation records of executives who worked with Leonard Mazur at Citius Pharmaceuticals in 2020.
News
Citius Pharmaceuticals CEO Leonard Mazur's 2023 pay jumps 66% to $2M
January 26, 2024
Citius Pharmaceuticals Chairman Myron Holubiak's 2022 pay falls 26% to $1.2M
December 22, 2022
Citius Pharmaceuticals CEO Myron Holubiak's 2021 pay jumps 91% to $1.7M
December 20, 2021
Citius Pharmaceuticals CEO Myron Holubiak's 2020 pay rises 15% to $875K
December 21, 2020
Citius Pharmaceuticals CEO Myron Holubiak's 2019 pay rises 12% to $764K
December 20, 2019
Citius Pharmaceuticals CEO Myron Holubiak's 2018 pay slips 2% to $681K
December 20, 2018